» Articles » PMID: 20658630

Prevalence of Daily Medication Adherence Among Children with Sickle Cell Disease: a 1-year Retrospective Cohort Analysis

Overview
Date 2010 Jul 27
PMID 20658630
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study is to determine the prevalence of adherence to daily medications among children with sickle cell disease (SCD). Prescription records for 12 months were obtained from participants who had insurance in a Medicaid-based single health maintenance organization. Adherence was measured as a ratio between the number of expected days and the observed days between two refill periods for daily medications. A total of 93 children were studied. The average refill prescription rate was 58.4%. More formal strategies are required to identify barriers to prescription refills among children with SCD.

Citing Articles

Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial.

Sasi P, Makubi A, Sangeda R, Ngaeje M, Mmbando B, Soka J Commun Med (Lond). 2024; 4(1):160.

PMID: 39122788 PMC: 11315961. DOI: 10.1038/s43856-024-00552-5.


Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.

Smaldone A, Manwani D, Aygun B, Appiah-Kubi A, Smith-Whitley K, Green N Pediatr Blood Cancer. 2024; 71(9):e31170.

PMID: 38975794 PMC: 11268999. DOI: 10.1002/pbc.31170.


Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.

Madkhali M, Abusageah F, Hakami F, Zogel B, Hakami K, Alfaifi S Medicina (Kaunas). 2024; 60(1).

PMID: 38256385 PMC: 10819561. DOI: 10.3390/medicina60010124.


Barriers to medication adherence in sickle cell disease: A comprehensive theory-based evaluation using the COM-B model.

King K, Cai S, Barrera L, Reddy P, Heneghan M, Badawy S Pediatr Blood Cancer. 2023; :e30440.

PMID: 37243925 PMC: 10679470. DOI: 10.1002/pbc.30440.


Development and Validation of the Patient/Caregiver Reported Hydroxyurea Evaluation of Adherence for Life (HEAL) Scale.

Janson I, Bloom E, Hampton K, Meier E, Rampersad A, Kronenberger W Patient Prefer Adherence. 2022; 16:3229-3239.

PMID: 36531301 PMC: 9749495. DOI: 10.2147/PPA.S387227.


References
1.
Gardiner P, Dvorkin L . Promoting medication adherence in children. Am Fam Physician. 2006; 74(5):793-8. View

2.
Weiden P, Kozma C, Grogg A, Locklear J . Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004; 55(8):886-91. DOI: 10.1176/appi.ps.55.8.886. View

3.
Haynes R, Ackloo E, Sahota N, McDONALD H, Yao X . Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011. DOI: 10.1002/14651858.CD000011.pub3. View

4.
Andrade S, Kahler K, Frech F, Chan K . Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006; 15(8):565-74. DOI: 10.1002/pds.1230. View

5.
Julius R, Novitsky Jr M, Dubin W . Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009; 15(1):34-44. DOI: 10.1097/01.pra.0000344917.43780.77. View